Desmoplastic melanoma: a diagnostic trap for the unwary

References

• Quinn MJ, Crotty KA, Thompson JF, Coates AS, O'Brien CJ, McCarthy WH. Desmoplastic and desmoplastic neurotropic mela-noma: experience with 280 patients. Cancer 1998; 83: 1128–35.
   Google Scholar
• Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 1971; 28: 914–36.
   Google Scholar
• Valensi QJ. Desmoplastic malignant melanoma: a report on two additional cases. Cancer 1977; 39: 286–92.
   PubMed Web of Science ®Google Scholar
• Reed RJ, Leonard DD. Neurotropic melanoma. A variant of desmoplastic melanoma. Am J Surg Pathol 1979; 3: 301–11.
   PubMed Web of Science ®Google Scholar
• Grunwald MH, Rothem A. Desmoplastic cartilaginous formation in malignant melanoma. J Cutan Pathol 1987; 14: 255.
   PubMed Web of Science ®Google Scholar
• Reiman HM, Goellner JR, Woods JE, Mixter RC. Desmoplastic melanoma of the head and neck. Cancer 1987; 60: 2269–74.
   PubMed Web of Science ®Google Scholar
• Walsh NM, Roberts JT, Orr W, Simon GT. Desmoplastic malignant melanoma. A clinicopathologic study of 14 cases. Arch Pathol Lab Med 1988; 112: 922–7.
   PubMed Web of Science ®Google Scholar
• Egbert B, Kempson R, Sagebiel R. Desmoplastic malignant melanoma. A clinicohistopathologic study of 25 cases. Cancer 1988; 62: 2033–41.
   Google Scholar
• Nakagawa H, Lee AY, Kikuchi K, et al. Desmoplastic malignant melanoma-an electron microscopic and immunohistochemical study of a case. J Dermatol 1988; 15: 161–7.
   PubMedGoogle Scholar
• Beenken S, Byers R, Smith JL, Goepfert H, Shallenberger R. Desmoplastic melanoma. Histologic correlation with behavior and treatment. Arch Otolaryngol Head Neck Surg 1989; 115: 374–9.
   PubMedGoogle Scholar
• Jain S, Allen PW. Desmoplastic malignant melanoma and its variants. A study of 45 cases. Am J Surg Pathol 1989; 13: 358–73.
   PubMed Web of Science ®Google Scholar
• Smithers BM, McLeod GR, Little JH. Desmoplastic, neural transforming and neurotropic melanoma: a review of 45 cases. Aust NZ J Surg 1990; 60: 967–72.
   Google Scholar
• Bruijn JA, Salasche S, Sober Ai, Mihm MC, Barnhill RL. Desmoplastic melanoma: clinicopathologic aspects of six cases. Dermatology 1992; 185: 3–8.
   Google Scholar
• Anstey A, McKee P, Jones EW. Desmoplastic malignant melanoma: a clinicopathological study of 25 cases. Br J Dermatol 1993; 129: 359–71.
   Google Scholar
• Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer 1995; 75: 478–94.
   Google Scholar
• Weinzweig N, Tuthill RJ, Yetman RJ. Desmoplastic malignant melanoma: a clinicohistopathologic review. Plast Reconstr Surg 1995; 95: 548–55.
   PubMed Web of Science ®Google Scholar
• Pearce RL. Subungual desmoplastic melanoma in an aboriginal woman. Med J Aust 1995; 162: 611–2.
   PubMed Web of Science ®Google Scholar
• Chung KC, Calkins ER, Crawford R, Rees RS. Desmoplastic melanoma of the hand: case reports and review of the literature. J Hand Surg (Am) 1995; 20: 873–6.
   PubMed Web of Science ®Google Scholar
• Rutten A, Hugel H, Kutzner H, Schirren CG, Kuchler A, Groth W. Desmoplastic malignant melanoma. Clinical and histopathologic results of a study in 34 patients. (German.) Hautarzt 1996; 47: 447–53.
   Google Scholar
• Kilpatrick SE, White WL, Browne JD. Desmoplastic malignant melanoma of the oral mucosa. An underrecognized diagnostic pitfall. Cancer 1996; 78: 383–9.
   Google Scholar
• Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol 1996; 20: 1489–500.
   Google Scholar
• Mulvany Ni, Sykes P. Desmoplastic melanoma of the vulva. Pathology 1997; 29: 241–5.
   PubMed Web of Science ®Google Scholar
• Tsao H, Sober Ai, Barnhill RL. Desmoplastic neurotropic melanoma. Semin Cutan Med Surg 1997; 16: 131–6.
   PubMed Web of Science ®Google Scholar
• Riccioni L, Di Tommaso L, Collina G. Actin-rich desmoplastic malignant melanoma: report of three cases. Am J Dermatopathol 1999; 21: 537–41.
   PubMed Web of Science ®Google Scholar
• Prasad ML, Patel SG, Busam KJ. Primary mucosal desmoplastic melanoma of the head and neck. Head Neck 2004; 26: 373–7.
   PubMed Web of Science ®Google Scholar
• Kay PA, Pinheiro AD, Lohse CM, et al. Desmoplastic melanoma of the head and neck: histopathologic and immunohistochemical study of 28 cases. Int j Surg Pathol 2004; 12: 17–24.
   PubMed Web of Science ®Google Scholar
• Su LD, Fullen DR, Lowe L, et al. Desmoplastic and neurotropic melanoma. Cancer 2004; 100: 598–604.
   PubMed Web of Science ®Google Scholar
• Bryant E, Ronan SG, Felix EL, Manaligod JR. Desmoplastic malignant melanoma: a study by conventional and electron micro-scopy. Am J Dermatopathol 1982; 4: 467–74.
   PubMed Web of Science ®Google Scholar
• Valensi QJ. Desmoplastic malignant melanoma: study of a case by light and electron microscopy. J Dermatol Surg Oncol 1979; 5: 31–5.
   PubMedGoogle Scholar
• Valensi QJ. Desmoplastic malignant melanoma: A light and electron microscopic study of two cases. Cancer 1979; 43: 1148–55.
   PubMed Web of Science ®Google Scholar
• From L, Hanna W, Kahn Hi, Gruss J, Marks A, Baumal R. Origin of the desmoplasia in desmoplastic malignant melanoma. Hum Pathol 1983; 14: 1072–80.
   PubMed Web of Science ®Google Scholar
• Gartner MF, Fearns C, Wilson EL, Campbell JA, Dowdle EB. Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression. Br J Cancer 1992; 65: 487–90.
   Google Scholar
• Fearns C, Dowdle EB. The desmoplastic response: induction of collagen synthesis by melanoma cells in vitro. Int J Cancer 1992; 50: 621–7.
   PubMed Web of Science ®Google Scholar
• Barnhill RL, Piepkorn M, Busam KJ. Pathology of Melanocytic Nevi and Malignant Melanoma. New York: Springer-Verlag, 2004.
   Google Scholar
• Gutzmer R, Herbst RA, Mommert S, et al. Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet 2000; 107: 357–61.
   PubMed Web of Science ®Google Scholar
• Rao UN, Bakker A, Swalsky PA, Finkelstein SD. Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma. Mod Pathol 1999; 12: 344–50.
   PubMed Web of Science ®Google Scholar
• Chan GS, Choy C, Ng WK, Chan KW. Desmoplastic malignant melanoma on the buttock of an 18-year-old girl: differentiation from desmoplastic nevus. Am J Dermatopathol 1999; 21: 170–3.
   PubMed Web of Science ®Google Scholar
• Hui JI, Linden KG, Barr RJ. Desmoplastic malignant melanoma of the lip: a report of 6 cases and review of the literature. J Am Acad Dermatol 2002; 47: 863–8.
   PubMed Web of Science ®Google Scholar
• Krenek G, Orengo IF, Baer S, Byrd D. Desmoplastic malignant melanoma presenting as an erythematous nodule tumor. Cutts 1998; 61: 275–6.
   PubMed Web of Science ®Google Scholar
• Crotty K, McCarthy W, Quinn M, McCarthy S. Alopecia neoplastica caused by desmoplastic melanoma. Australas J Dermatol 2003; 44: 295–8.
   PubMedGoogle Scholar
• Moreno A, Lamarca J, Martinez R, Guix M. Osteoid and bone formation in desmoplastic malignant melanoma. J Cutan Pathol 1986; 13: 128–34.
   PubMed Web of Science ®Google Scholar
• Eng W, Tschen JA. Comparison of S-100 versus hematoxylin and eosin staining for evaluating dermal invasion and peripheral margins by desmoplastic malignant melanoma. Am J Dermatopathol 2000; 22: 26–9.
   PubMed Web of Science ®Google Scholar
• Skelton HG, Maceira J, Smith KJ, McCarthy WF, Lupton GP, Graham JH. HMB45 negative spindle cell malignant melanoma. Am J Dermatopathol 1997; 19: 580–4.
   PubMed Web of Science ®Google Scholar
• Busam KJ, Iversen K, Coplan KC, Jungbluth AA. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001; 25: 197–204.
   PubMed Web of Science ®Google Scholar
• Granter SR, Weilbaecher KN, Quigley C, Fletcher CD, Fisher DE. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol 2001; 23: 185–9.
   Google Scholar
• Clarkson KS, Sturdgess IC, Molyneux AJ. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A). J Clin Pathol 2001; 54: 196–200.
   Google Scholar
• Iwamoto S, Burrows RC, Agoff SN, Piepkorn M, Bothwell M, Schmidt R. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas. Am J Dermatopathol 2001; 23: 288–94.
   PubMed Web of Science ®Google Scholar
• Iwamoto S, Odland PB, Piepkorn M, Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996; 35: 725–31.
   PubMed Web of Science ®Google Scholar
• Barr RJ, Morales RV, Graham JH. Desmoplastic nevus: a distinct histologic variant of mixed spindle cell and epithelioid cell nevus. Cancer 1980; 46: 557–64.
   Google Scholar
• Harris GR, Shea CR, Horenstein MG, Reed JA, Burchette JL Jr, Prieto VG. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol 1999; 23: 786–94.
   PubMed Web of Science ®Google Scholar
• Bergman R, Dromi R, Trau H, Cohen I, Lichtig C. The pattern of HMB-45 antibody staining in compound Spitz nevi. Am J Dermatopathol 1995; 17: 542–6.
   Google Scholar
• Michal M, Kerekes Z, Kinkor Z, Ondrias F, Pizinger K. Desmoplastic cellular blue nevi. Am J Dermatopathol 1995; 17: 230–5.
   PubMed Web of Science ®Google Scholar
• Robson A, Allen P, Hollowood K. S100 expression in cutaneous scars: a potential diagnostic pitfall in the diagnosis of desmoplastic melanoma. Histopathology 2001; 38: 135–40.
   Google Scholar
• Chorny JA, Barr RJ. S100-positive spindle cells in scars: a diagnostic pitfall in the re-excision of desmoplastic melanoma. Am J Dermatopathol 2002; 24: 309–12.
   PubMed Web of Science ®Google Scholar
• Kubo M, Kikuchi K, Nashiro K, et al. Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 1998; 139: 192–7.
   PubMed Web of Science ®Google Scholar
• Baer SC, Schultz D, Synnestvedt M, Elder DE. Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma. Cancer 1995; 76: 2242–7.
   Google Scholar
• Vongtama R, Safa A, Gallardo D, Calcaterra T, Juillard G. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma. Head Neck 2003; 25: 423–8.
   Google Scholar
• Gyorki DE, Busam K, Panageas K, Brady MS, Coit DG. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 2003; 10: 403–7.
   Google Scholar
• McCarthy SW, Crotty KA, Scolyer RA. Desmoplastic melanoma and desmoplastic neurotropic melanoma. In: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Skin. Lyon: IARC Press, (in press).
   Google Scholar